DE60029937D1 - Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung - Google Patents

Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung

Info

Publication number
DE60029937D1
DE60029937D1 DE60029937T DE60029937T DE60029937D1 DE 60029937 D1 DE60029937 D1 DE 60029937D1 DE 60029937 T DE60029937 T DE 60029937T DE 60029937 T DE60029937 T DE 60029937T DE 60029937 D1 DE60029937 D1 DE 60029937D1
Authority
DE
Germany
Prior art keywords
analogues
adhesion formation
scars
angiotensin
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029937T
Other languages
English (en)
Other versions
DE60029937T2 (de
Inventor
Kathleen Rodgers
Gere Dizerega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Application granted granted Critical
Publication of DE60029937D1 publication Critical patent/DE60029937D1/de
Publication of DE60029937T2 publication Critical patent/DE60029937T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60029937T 1999-03-23 2000-03-22 Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung Expired - Lifetime DE60029937T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12570799P 1999-03-23 1999-03-23
US125707P 1999-03-23
US13954199P 1999-06-16 1999-06-16
US139541P 1999-06-16
PCT/US2000/007669 WO2000056345A2 (en) 1999-03-23 2000-03-22 Methods for limiting scar and adhesion formation

Publications (2)

Publication Number Publication Date
DE60029937D1 true DE60029937D1 (de) 2006-09-21
DE60029937T2 DE60029937T2 (de) 2007-09-06

Family

ID=26823846

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029937T Expired - Lifetime DE60029937T2 (de) 1999-03-23 2000-03-22 Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung

Country Status (8)

Country Link
EP (1) EP1165099B1 (de)
JP (1) JP3745624B2 (de)
AT (1) ATE335496T1 (de)
AU (1) AU756156B2 (de)
CA (1) CA2367107C (de)
DE (1) DE60029937T2 (de)
ES (1) ES2267513T3 (de)
WO (1) WO2000056345A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
ZA200804907B (en) 2004-08-18 2009-04-29 Ace Aps Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
CA2623471C (en) * 2004-09-23 2018-02-13 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
WO2011120032A1 (en) * 2010-03-26 2011-09-29 University Of Southern California Methods for treating combined radiation and thermal injury
EP2455388A1 (de) 2010-11-23 2012-05-23 LanthioPep B.V. Neuartige Rezeptoragonisten von Angiotensin des Typs 2 (AT2) und Verwendungen dafür
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
CN111163793A (zh) * 2017-07-17 2020-05-15 莫纳什大学 血管紧张素受体激动剂及其用途
JP2022542437A (ja) 2019-08-02 2022-10-03 ランティオペプ ベスローテン ヴェンノーツハップ 癌の処置に用いるアンジオテンシン２型（ａｔ２）受容体アゴニスト

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008565A1 (en) * 1993-09-24 1995-03-30 The University Of Southern California Use of angiotensin ii analogs in tissue repair
AU6650098A (en) * 1997-02-04 1998-08-25 University Of Southern California Method for accelerating healing of thermal injuries

Also Published As

Publication number Publication date
DE60029937T2 (de) 2007-09-06
EP1165099B1 (de) 2006-08-09
EP1165099A2 (de) 2002-01-02
ATE335496T1 (de) 2006-09-15
WO2000056345A2 (en) 2000-09-28
CA2367107C (en) 2003-10-14
WO2000056345A9 (en) 2002-06-27
WO2000056345A3 (en) 2001-01-11
AU3911700A (en) 2000-10-09
CA2367107A1 (en) 2000-09-28
JP2002539267A (ja) 2002-11-19
AU756156B2 (en) 2003-01-02
ES2267513T3 (es) 2007-03-16
JP3745624B2 (ja) 2006-02-15

Similar Documents

Publication Publication Date Title
WO2000053211A3 (en) Method of promoting myocyte proliferation and myocardial tissue repair
BR0112292A (pt) Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
MY138289A (en) Pharmaceutical compositions
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
ATE410996T1 (de) Methoden zur behandlung von nägeln
ATE266675T1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
DE60029937D1 (de) Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
ATE314062T1 (de) Zusammensetzungen zur abgabe von cortisolantagonisten
SE0202598D0 (sv) Alpha-7 Nicotinic receptor agonists and statins in combination
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
WO2004009773A3 (en) Methods and compositions for activating or inhibiting vegf-d and vegf-c
CA2323237A1 (en) Improved radiation therapy methods
ES2167364T3 (es) Inhibidores de trombina.
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
EA200601592A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
WO2002006308A3 (en) Methods for promoting dendritic cell proliferation or differentiation
WO2001044270A3 (en) Methods for treating and preventing diabetic complications by use of angiotensin-related peptides
AU2003251728A1 (en) Placental growth factor as a target for the treatment of osteoporosis
WO2001055176A3 (en) Methods for inhibiting smooth muscle cell proliferation
DE60017793D1 (de) Verfahren zur vorbeugung und behandlung von beschädigung des schleimhautgewebes
DK0833848T3 (da) Faktor IX-bindende peptider afledt af faktor VIII og anvendelse heraf som inhibitorer af blodkoagulation
ATE374180T1 (de) N-acylpyrrolidin-2-ylalkylbenzamidin-derivate als inhibitoren von factor xa
BR0317119A (pt) Agente antitumor, inibidor de proliferação celular, e, análogo de 3-fenil-cinolina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition